Rhythm Biosciences Limited (RHY)
ASX
The current RHY market cap is 21.15M. The company's latest EPS is AUD -0.0279 and P/E is -3.23.
Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Revenue | 100k | 1.11M | 2.43M | 3.1M | 1.69M |
Operating Income | -4.06M | -6.63M | -8.82M | -8.45M | -3.86M |
Net Income | -4.02M | -6.61M | -8.79M | -8.22M | -6.86M |
Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Assets | 2.65M | 3.07M | 8.44M | 7.7M | 1.52M |
Total Liabilities | 803k | 1.36M | 1.07M | 1.82M | 652k |
Total Equity | 1.84M | 1.71M | 7.37M | 5.87M | 867k |
Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Operating | -2.74M | -5.4M | -6.5M | -6.96M | -6.14M |
Investing | -46k | -68k | -27k | -99k | -82k |
Financing | -142k | 5.9M | 11.85M | 3.63M | 2.81M |
Market Cap | 21.15M |
Price to Earnings Ratio | -3.23 |
Price to Sales Ratio | 13.04 |
Price to Cash Ratio | 31.03 |
Price to Book Ratio | 25.53 |
Dividend Yield | - |
Shares Outstanding | 245.98M |
Average Volume (1 week) | 220k |
Average Volume (1 Month) | 349.42k |
52 Week Change | -25.22% |
52 Week High | 0.185 |
52 Week Low | 0.042 |
Spread (Intraday) | 0 (1.16%) |
Company Name | Rhythm Biosciences Limited |
Address |
bio21 institute melbourne, victoria 3010 |
Website | https://www.rhythmbio.com |
Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.